United States· US:69452-157_bc889905-a174-9524-e053-2995a90a679c

RIZATRIPTAN BENZOATE

A medicinal product containing rizatriptan benzoate, registered in United States by Bionpharma Inc.,.

US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about rizatriptan benzoateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: RIZATRIPTAN BENZOATE
Manufacturer: Bionpharma Inc.,
Country: United States (US)
ATC code: —
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
6945215773
6 BLISTER PACK in 1 CARTON (69452-157-73) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (69452-157-74)
ndc11
69452-157-73

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rizatriptan benzoate in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rizatriptan benzoate products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Maxalt, Maxalt Rapitab
Belgium · Maxalt, Maxalt Lyo
Germany · Maxalt, Maxalt Lingua
Denmark · Maxalt Smelt, Rizatripan
Spain · Maxalt, Maxalt Max
Finland · Maxalt, Maxalt Rapitab
France · Maxalt, Maxaltlyo
United Kingdom (Northern Ireland) · Maxalt, Maxalt Melt
Greece · Flixan, Maxalt
Croatia · Maxalt Rpd
Hungary · Calvinia
Ireland · Rizadia
Iceland · Maxalt Smelt, Rizatriptan Alvogen
Italy · Emirizia, Maxalt
Lithuania · Maxalt
Luxembourg · Maxalt Lyo
Latvia · Calvinia
Malta · Rizatriptan Aurobindo Pharma (Malta)
Netherlands · Maxalt, Maxalt Smelt
Norway · Maxalt, Maxalt Rapitab
Poland · Migrenofen
Portugal · Maxalt, Rizatriptano Zim
Romania · Maxalt
Sweden · Maxalt, Maxalt Rapitab
Slovakia · Maxalt Rpd

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/adf58265-4e29-48d5-8f3e-7e79d8a4e218
GET /v1/drugs/adf58265-4e29-48d5-8f3e-7e79d8a4e218?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10",
  "substance": "RIZATRIPTAN BENZOATE",
  "productndc": "69452-157",
  "dosage_form": "TABLET, ORALLY DISINTEGRATING",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA204722",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about rizatriptan benzoate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console